119P - ERBB2 mRNA as a predictor in HER2-positive (HER2+)/hormone receptor-positive (HR+) metastatic breast cancer (BC) treated with HER2 blockade in combination with endocrine the... von Chic, N., Pascual, T., Brasó-Maristany, F., Villagrasa Gonzalez, P., Pare Brunet, L., Schettini, F., Conte, B., Adamo, B., Vidal, M., Muñoz, M., Martínez, O., Gonzalez-Farre, B., Cortés, J., Llombart-Cussac, A., Rodrik-Outmezguine, V., Izquierdo Delso, M.A., Schiff, R., Osborne, C.K., Rimawi, M., Prat, A.

Volltext

ERBB2 mRNA as a predictor in HER2-positive (HER2+)/hormone receptor-positive (HR+) metastatic breast cancer (BC) treated with HER2 blockade in combination with endocrine therapy (E... von Chic, N., Pascual, T., Brasó-Maristany, F., Villagrasa Gonzalez, P., Pare Brunet, L., Schettini, F., Conte, B., Adamo, B., Vidal, M., Muñoz, M., Martínez, O., Gonzalez-Farre, B., Cortés, J., Llombart-Cussac, A., Rodrik-Outmezguine, V., Izquierdo Delso, M.A., Schiff, R., Osborne, C.K., Rimawi, M., Prat, A.

Volltext

Adjuvant anti-HER2 therapy, treatment-induced amenorrhea (TIA) and survival in premenopausal patients (pts) with HER2-positive (HER2+) early breast cancer (EBC): Analysis from the... von Lambertini, M., Campbell, C., Bines, J., Korde, L., Izquierdo Delso, M.A., Fumagalli, D., Pritchard, K., Wolff, A., Jackisch, C., Lang, I., Untch, M., Smith, I., Boyle, F.M., Xu, B., Barrios, C.H., Baselga, J., Moreno-Aspitia, A., Piccart, M., Gelber, R., De Azambuja, E.

Volltext